Depression and Anxiety Trial, Recruiting NCT06651801 Sponsor: University of Manitoba Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT06651801
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults who have been referred to Central Intake for a psychiatric consultation by their family doctor or primary care provider, where the main mental health concern is an anxiety disorder (such as social anxiety, generalized anxiety, or panic disorder) or depression (such as major depressive disorder or persistent depressive disorder)
  • People who are able to participate in group sessions held in English, with up to 10 participants
  • People who are able to attend a virtual group session every two weeks, with each session lasting about 1.5 hours
  • People who have access to a private location and a camera to join the virtual group sessions
  • People who currently live in the community in Manitoba and plan to remain there for at least 6 months

Who may not be able to join:

  • People who have been diagnosed with Bipolar Disorder (Type 1 or Type 2), even if they are currently experiencing a depressive episode
  • People whose primary diagnosis is a personality disorder that is causing their anxiety or depression symptoms (having personality disorder traits alone is not an exclusion)
  • People who already have an ongoing, established care relationship with a psychiatrist
  • People who have received electroconvulsive therapy (ECT) — a brain stimulation treatment — within the past 6 months
  • People with a moderate-to-severe substance use disorder, particularly where substances are used throughout the day or where attending the group without using substances beforehand would not be possible
  • People who are currently experiencing psychotic symptoms (such as hallucinations or delusions)
  • People with a moderate-to-severe intellectual disability or significant cognitive impairment
  • People who are currently experiencing significant eating disorder symptoms — for example, those causing notable weight loss, malnutrition, or taking up a large part of daily life mentally or physically
  • People who have engaged in self-harm requiring medical or psychiatric attention, or who have had active suicidal thoughts or suicide attempts within the past 6 months
  • People whose participation may raise safety concerns for other group members or facilitators

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 204-787-7949

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Manitoba
Registry
ClinicalTrials.gov
Start date
15 April 2025
Est. completion
1 November 2025

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Client Satisfaction Questionnaire-4 Scale (CSQ-4); Recruitment and Retention Rate; Primary Care Provider Satisfaction with Psychiatric Care

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov